LO-Pharma SRL
1.3 FTELO-Pharma reported total assets of 597,566 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026), with 1.3 full-time equivalent.
The score of LO-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +9 % Total assets -14 % Headcount (avg FTE) -13 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
LO-Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −15,388 € | ||||
| Equity | 79,136 € | ||||
| Cash | 53,775 € | ||||
| EBITDA | 54,859 € | ||||
| Total assets | 597,566 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 21 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 08 Aug 2022
LO-Pharma's financial analysis
- Solvency13.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of LO-Pharma
LO-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0807.456.110
- VAT number
- BE0807456110
- Peppol
- Registered · 0208:0807456110 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Oct 2008
- Registered office
- 3212 Lubbeek
- Size
- Micro · 1.3 FTE
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
LO-Pharma (SRL) has been based in Lubbeek since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 15,388 € and equity of 79,136 €; its revenue is not published. With 1.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 13.2%, below the median of its sector (44.2%).
Companies similar to LO-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Codden Retail sale of pharmaceutical products Manage · balance sheet 597,613 €
- Jacky-Mo Retail sale of pharmaceutical products Schaerbeek · balance sheet 597,743 €
- Apotheek Pieters Retail sale of pharmaceutical products Antwerp · balance sheet 597,768 €
- Stella and Maynard Retail sale of pharmaceutical products Ghent · balance sheet 597,024 €
- Dubart - Lamalle Retail sale of pharmaceutical products Chaudfontaine · balance sheet 599,335 €
- Etis Pharma Retail sale of pharmaceutical products Pont-à-Celles · balance sheet 599,365 €
- DE Bosmolens Retail sale of pharmaceutical products Izegem · balance sheet 599,551 €
- Diapharma Retail sale of pharmaceutical products Leuven · balance sheet 600,343 €
Frequently asked questions about LO-Pharma
What is the revenue of LO-Pharma?
LO-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of LO-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0807456110 for LO-Pharma, if the company is VAT-registered. Its company number (CBE) is 0807.456.110.
Where is the registered office of LO-Pharma?
According to the CBE register, the registered office of LO-Pharma is in 3212 Lubbeek.
What is the equity of LO-Pharma?
At the close of the 2025 financial year, the equity of LO-Pharma amounts to 79,136 €, a solvency of 13.2% of total assets.
How many people work at LO-Pharma?
1.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages LO-Pharma?
The register lists 2 active mandates at LO-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of LO-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →